Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: A prospective, long-term, follow-up, workplace outcome study

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 1, 2002, Pages 61-69

  Madisch, Ahmed ^a   Hotz, Jürgen ^a   Grabowski, Gabriele ^a   Guth, Angelika ^a   Malfertheiner, Peter ^a   Plein, Klaus ^a   Schneider, Berthold ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Helicobacter pylori; Helicobacter pylori eradication; Occupational medicine; Quality of life; Test and treat strategy; Uninvestigated dyspepsia

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DYSPEPSIA; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE VALUE; TREATMENT OUTCOME; UREA BREATH TEST; WORKPLACE;

ADULT; CHRONIC DISEASE; COST OF ILLNESS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HEALTH SERVICES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; QUALITY OF LIFE;

EID: 0036152479     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200201000-00011     Document Type: Article

References (40)

1. Evaluation of dyspepsia
2. Dyspepsia in England and Scotland
3. Dyspepsia and dyspepsia subgroups: A population-based study
4. Helicobacter pylori infection and dyspepsia
5. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up
6. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia
7. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
8. What role does Helicobacter pylori play in dyspepsia and non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms
9. Alternative management strategies for patients with suspected peptic ulcer disease
10. Current European concepts in the management of Helicobacter pylori infection
11. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia
12. H. pylori testing or prompt endoscopy for management of dyspeptic patients: A randomized trial
13. A prospective randomised trial of a 'test and treat' policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic
14. 13C-urea breath test for pre- and post-treatment diagnosis of Helicobacter pylori infection in the clinical routine setting
15. 13C-urea breath test for the diagnosis of Helicobacter pylori infection
16. Dyspepsia in healthy blood donors: Pattern of symptoms and association with Helicobacter pylori
17. Helicobacter pylori infection: Prevalence and clinical relevance in a large company
18. Gastrointestinal and liver disorders
19. AGA technical review: Evaluation of dyspepsia
20. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects
21. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences
22. Cost effectiveness of screening for and eradication of Helicobacter pylori in the management of dyspeptic patients under 45 years of age
23. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status
24. Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations
25. Epidemiology of Helicobacter pylori infection
26. Non-ulcer dyspepsia and short term De-Nol therapy: A placebo controlled trial with particular reference to the role of Campylobacter pylori
27. Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics
28. Socioeconomic factors in Helicobacter pylori infection among Danish adults
29. A population based study of Helicobacter pylori infection in a European country: The San Marino study. Relations with gastrointestinal diseases
30. Helicobacter pylori in Hispanics: Comparison with blacks and whites of similar age and socioeconomic class
31. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection
32. Italian omeprazole triple therapy - A 1 week regimen
33. Determination of the optimum dose of omeprazole in a new triple therapy regime for eradicating Helicobacter pylori
34. One week low-dose triple therapy for the eradication of Helicobacter pylori infection
35. Evaluation of a short-term low dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study
36. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia
37. The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community
38. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients
39. Nonulcer dyspepsia: Potential causes and pathophysiology
40. Gastrointestinal endoscopy in the young